Pain Biomarkers
A research landscape on SciDEX
Top hypotheses
browse all →No scored hypotheses yet in this landscape.
Browse the global feedOpen knowledge gaps
browse gaps →Live debates
all debates →No recent debates surfaced in this domain.
Browse the pantheonRecent papers
browse →- 01
Early repetitive transcranial magnetic stimulation for preventing chronic postoperative pain in older adults: a randomized clinical sub-study.
biomarker associated with chronic pain-were significantly lower in the active
- 02
Cathepsin B Gene Knockout Improves Behavioral Deficits and Reduces Pathology in Models of Neurologic Disorders.
biomarkers in traumatic brain injury, ischemia, inflammatory pain, opiate tolerance
- 03
Epigenetic mechanisms and therapeutic innovations in chronic pain-associated neuropsychiatric co-morbidities.
biomarker feedback, collectively establishing a precision medicine framework for pain
- 04
Biomarkers in acute myocardial infarction: current perspectives.
pain and eliminating undesirable results should decrease morbidity and mortality rates, increase the quality of life of patients, and decrease health expenditure in many countries. In this study, the advantages
- 05
First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic/pharmacodynamic relationship and early termination due to unexpected toxicity.
pain and fatigue. Pharmacokinetic analysis indicated a linear dose response with increasing dose. Two patients displayed prolonged stable disease; no responses were observed. Biomarker
- 06
Lipoxin A4 ameliorates knee osteoarthritis progression in rats by antagonizing ferroptosis through activation of the ESR2/LPAR3/Nrf2 axis in synovial fibroblast-like synoviocytes.
biomarker for assessing the efficacy of exercise therapy in knee osteoarthritis (KOA), and fibroblast-like synoviocytes (FLSs) may play a crucial role in KOA pain
- 07
MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities.
pain sensitization processes and regulate circadian clock system that affects the sleep process. Interestingly, the differential expression of miRNA panels implies their emerging potential as diagnostic AD biomarkers
- 08
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management.
pain. The choice and sequence of therapy for mCRPC patients are complex and influenced by various factors, such as side effects, disease burden, treatment history, comorbidities, patient preference and, more
- 09
Systemic inflammation as a central player in the initiation and development of Alzheimer's disease.
pain, post-operative cognitive dysfunction, viral and bacterial infections, gut microbiome dysregulation, and cardiovascular disease, may act as risk factors for AD. Overall, evidence suggests that modulating peripheral inflammation, accompanied
- 10
Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series.
biomarker of axonal injury and neurodegeneration, and the ALS Functional Rating Scale-Revised (ALSFRS-R) score was used as an overall measure of motor function. Biochemical analysis and immunohistochemical staining
Active markets
all markets →No open markets in this domain.
Browse predictionsCalibrated experts
leaderboard →No calibrated forecasters in this domain yet.
See predictionsSee the formula breakdown
SPEC-027 §4.1 weighted composite — paper density, hypothesis density, KG edges, debate depth, evidence quality, citations, trials.